Literature DB >> 31429170

An explanation for posttransplant late-onset disease associated with CMV prophylaxis.

Paul D Griffiths1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31429170     DOI： 10.1002/rmv.2080

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN： 1052-9276            Impact factor:   6.989


× No keyword cloud information.
  1 in total

1.  Assessing Anti-HCMV Cell Mediated Immune Responses in Transplant Recipients and Healthy Controls Using a Novel Functional Assay.

Authors:  Charlotte J Houldcroft; Sarah E Jackson; Eleanor Y Lim; George X Sedikides; Emma L Davies; Claire Atkinson; Megan McIntosh; Ester B M Remmerswaal; Georgina Okecha; Frederike J Bemelman; Richard J Stanton; Matthew Reeves; Mark R Wills
Journal:  Front Cell Infect Microbiol       Date:  2020-06-26       Impact factor: 5.293
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.